Literature DB >> 19554290

Display and selection of scFv antibodies on HEK-293T cells.

Mitchell Ho1, Ira Pastan.   

Abstract

We describe a human cell display strategy to isolate high-affinity single-chain antibody fragments (scFvs) specific for CD22 for the treatment of B-cell malignancies. Our strategy uses flow cytometry and human embryonic kidney 293T (HEK-293T) cells that are widely used for transient protein expression. Flow cytometry enhances the screen's sensitivity thereby allowing us to isolate high-affinity scFvs. Using human cell display, one could isolate and engineer scFvs, single domains, Fabs, or whole IgGs for increased affinity and other biological functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554290      PMCID: PMC2790380          DOI: 10.1007/978-1-60327-302-2_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Monoclonal antibody therapy of cancer.

Authors:  Gregory P Adams; Louis M Weiner
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 2.  Selecting and screening recombinant antibody libraries.

Authors:  Hennie R Hoogenboom
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

3.  Yeast surface display for screening combinatorial polypeptide libraries.

Authors:  E T Boder; K D Wittrup
Journal:  Nat Biotechnol       Date:  1997-06       Impact factor: 54.908

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Kinetic and affinity limits on antibodies produced during immune responses.

Authors:  J Foote; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 6.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

Authors:  Mitchell Ho; Satoshi Nagata; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-08       Impact factor: 11.205

8.  Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library.

Authors:  Michael J Feldhaus; Robert W Siegel; Lee K Opresko; James R Coleman; Jane M Weaver Feldhaus; Yik A Yeung; Jennifer R Cochran; Peter Heinzelman; David Colby; Jeffrey Swers; Christilyn Graff; H Steven Wiley; K Dane Wittrup
Journal:  Nat Biotechnol       Date:  2003-01-21       Impact factor: 54.908

Review 9.  Mesothelin targeted cancer immunotherapy.

Authors:  Raffit Hassan; Mitchell Ho
Journal:  Eur J Cancer       Date:  2007-10-22       Impact factor: 9.162

Review 10.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

View more
  12 in total

1.  Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.

Authors:  Vahideh Valizadeh; Sedigheh Zakeri; Akram A Mehrizi; Sedigheh Mirkazemi; Navid D Djadid
Journal:  Med Microbiol Immunol       Date:  2015-08-05       Impact factor: 3.402

Review 2.  In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries.

Authors:  Ryan M Williams; Letha J Sooter
Journal:  J Immunol Res       Date:  2015-09-07       Impact factor: 4.818

3.  A Novel Dual Expression Platform for High Throughput Functional Screening of Phage Libraries in Product like Format.

Authors:  Xiaodong Xiao; Yan Chen; Sheila Mugabe; Changshou Gao; Christine Tkaczyk; Yariv Mazor; Peter Pavlik; Herren Wu; William Dall'Acqua; Partha Sarathi Chowdhury
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

4.  Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.

Authors:  Christopher A Lino; Jerri C Caldeira; David S Peabody
Journal:  J Nanobiotechnology       Date:  2017-02-13       Impact factor: 10.435

5.  Transient AID expression for in situ mutagenesis with improved cellular fitness.

Authors:  Talal Salem Al-Qaisi; Yu-Cheng Su; Steve R Roffler
Journal:  Sci Rep       Date:  2018-06-20       Impact factor: 4.379

6.  SARS-CoV-2 neutralizing antibody development strategies.

Authors:  Bertan Koray BalcioĞlu; Melis Denİzcİ ÖncÜ; Hasan Ümit ÖztÜrk; Fatıma YÜcel; Filiz Kaya; Müge Serhatli; Hivda ÜlbeĞİ Polat; Şaban Tekİn; Aylin Özdemİr Bahadir
Journal:  Turk J Biol       Date:  2020-06-21

7.  Monoclonal antibodies from a patient with anti-NMDA receptor encephalitis.

Authors:  Rashmi Sharma; Fetweh H Al-Saleem; Jessica Panzer; Jiwon Lee; Rama Devudu Puligedda; Liza F Felicori; Chandana Devi Kattala; Amy J Rattelle; Gregory Ippolito; Robert H Cox; David R Lynch; Scott K Dessain
Journal:  Ann Clin Transl Neurol       Date:  2018-07-05       Impact factor: 4.511

8.  Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis.

Authors:  Rashmi Sharma; Fetweh H Al-Saleem; Rama Devudu Puligedda; Amy Rattelle; David R Lynch; Scott K Dessain
Journal:  BMC Biotechnol       Date:  2018-06-27       Impact factor: 2.563

9.  Display of human and rabbit monocyte chemoattractant protein-1 on human embryonic kidney 293T cell surface.

Authors:  Maryam Boshtam; Seddigheh Asgary; Ilnaz Rahimmanesh; Shirin Kouhpayeh; Jamal Naderi; Zahra Hejazi; Hoda Mohammad-Dezashibi; Ina Laura Pieper; Hossein Khanahmad
Journal:  Res Pharm Sci       Date:  2018-10

Review 10.  Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.

Authors:  Mohamed A Alfaleh; Hashem O Alsaab; Ahmad Bakur Mahmoud; Almohanad A Alkayyal; Martina L Jones; Stephen M Mahler; Anwar M Hashem
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.